CytRx Hit With Investor Suit Related To FDA Hold On Drug
CytRx Corp. was hit with a proposed securities class action Monday in California federal court by investors who say the biopharmaceutical company concealed bad news affecting the company's business arising from...To view the full article, register now.
Already a subscriber? Click here to view full article